Ultragenyx Pharmaceutical RARE Goodwill
Goodwill at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's goodwill?
- Ultragenyx Pharmaceutical (RARE) reported goodwill of $44M in Q1 2026.
- How has Ultragenyx Pharmaceutical's goodwill changed year-over-year?
- Ultragenyx Pharmaceutical's goodwill decreased by 0.9% year-over-year, from $44.41M to $44M.
- What is the long-term trend for Ultragenyx Pharmaceutical's goodwill?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's goodwill has grown at a -0.2% compound annual growth rate (CAGR), from $44.41M to $44M.
- What does goodwill mean?
- The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.